Filing Details
- Accession Number:
- 0001209191-23-005896
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-01 16:00:11
- Reporting Period:
- 2023-01-30
- Accepted Time:
- 2023-02-01 16:00:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1736295 | E Maria Pasquale | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-30 | 12,865 | $65.36 | 81,389 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-30 | 12,865 | $84.69 | 68,524 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-01-30 | 10,438 | $68.62 | 78,962 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-30 | 10,438 | $84.70 | 68,524 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-01-30 | 11,861 | $72.27 | 80,385 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-30 | 11,861 | $84.70 | 68,524 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-01-30 | 14,374 | $80.50 | 82,898 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-30 | 14,374 | $84.73 | 68,524 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-01-30 | 5,644 | $83.58 | 74,168 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-30 | 5,644 | $85.07 | 68,524 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-01-30 | 4,842 | $74.78 | 73,366 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-30 | 4,842 | $84.73 | 68,524 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-01-30 | 12,865 | $0.00 | 12,865 | $65.36 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-01-30 | 10,438 | $0.00 | 10,438 | $68.62 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-01-30 | 11,861 | $0.00 | 11,861 | $72.27 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-01-30 | 14,374 | $0.00 | 14,374 | $80.50 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-01-30 | 5,644 | $0.00 | 5,644 | $83.58 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-01-30 | 4,842 | $0.00 | 4,842 | $74.78 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-04-08 | No | 4 | M | Direct | |
| 0 | 2028-07-01 | No | 4 | M | Direct | |
| 0 | 2029-01-03 | No | 4 | M | Direct | |
| 0 | 2030-01-16 | No | 4 | M | Direct | |
| 0 | 2031-07-01 | No | 4 | M | Direct | |
| 0 | 2032-01-18 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Includes an aggregate of 49,571 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
- Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting on April 9, 2019 and the remainder vesting monthly over three years.
- Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.
- Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.
- Beginning January 17, 2020, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2020 and the remainder vesting monthly over three years.
- Beginning July 2, 2021, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years.
- Beginning January 2, 2022, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years.
Billionaire Hedge Funds
